Diagnostic Accuracy in Fit-for-Purpose PD-L1 Testing
暂无分享,去创建一个
Jennifer Won | John Garratt | Carol C Cheung | Hyun J Lim | C Blake Gilks | Emina E Torlakovic | C. Gilks | C. Cheung | E. Torlakovic | John Garratt | H. Lim | Jennifer R. Won | Carol C. Cheung
[1] N. Le Stang,et al. Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] Anthony Rhodes,et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). , 2010, Archives of pathology & laboratory medicine.
[4] Clive R. Taylor,et al. Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1 Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers , 2017, Applied immunohistochemistry & molecular morphology : AIMM.
[5] Johannes B Reitsma,et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration , 2016, BMJ Open.
[6] M. Tiemann,et al. Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas , 2016, Modern Pathology.
[7] M. Hammond,et al. Recommendations for validating estrogen and progesterone receptor immunohistochemistry assays. , 2010, Archives of pathology & laboratory medicine.
[8] A. Marchetti,et al. Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD‐L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.